Oregon Recalls THC Vape Pods Containing Unapproved Additives

Aug.24.2022
Oregon Recalls THC Vape Pods Containing Unapproved Additives
18,000 THC e-cigarette pods recalled in Oregon due to unauthorized non-cannabis additives, potentially causing respiratory issues.

During an investigation conducted by the Oregon Liquor Control Commission (OLCC) this month, it was found that over 18,000 THC (tetrahydrocannabinol) electronic cigarette pods sold in Oregon between November 2021 and July 2022 contained unapproved non-cannabis additives, which could potentially pose health issues for the respiratory system.


Here is what the recall for the electronic cigarettes shopping cart label looks like:


The marijuana regulatory agency in the state of Oregon has issued a recall for 18,000 electronic THC vape pods manufactured by YHN. The recall notice is printed on the back of the packaging (as shown in the photo from OLCC). The OLCC has initiated the recall of these pods, which were manufactured by YHN and sold in two stores located in the eastern Oregon town of Ontario.


Weedology and The Bud House are two pharmacies in Ontario that sell electronic cigarette pods. They have voluntarily pulled the recalled YHN products from their shelves. So far, the OLCC has not received any reports from consumers who have experienced negative health effects from using these YHN products.


We encourage consumers who have purchased unapproved products to return them to OLCC-licensed retailers or dispose of them. Individuals who have health concerns regarding recalled e-cigarette products should contact their healthcare provider.


The main culprit: Soybean oil.


As part of their ongoing independent investigation, officials from the OLCC tested a range of products from the YHN brand and found that some of their flavoring cartridges for inhalable cannabis may contain soybean oil, which contains triglycerides of glycerol and is prohibited for use in e-cigarette products in Oregon.


Soybean oil is considered a generally recognized as safe (GRAS) food additive by the U.S. Food and Drug Administration. However, this classification is based on ingestion rather than inhalation. When soybean oil is heated into vapor and inhaled, the triglycerides in it may cause various long and short-term health problems, including lipoid pneumonia, a rare lung disease that can cause lung inflammation and breathing difficulties.


Risk: Lipoid Pneumonia


According to data from the National Institutes of Health in the United States, the incidence of lipoid pneumonia is increasing with the rise of nicotine and tetrahydrocannabinol (THC) electronic cigarettes.


According to the National Institutes of Health, an electronic cigarette is defined as a device that uses heat to produce aerosol inhaled by the user from a liquid containing various chemicals, including but not limited to nicotine, artificial flavors, or marijuana. Their guidelines were last updated as of June 2022. A series of cases completed in North Carolina observed five previously healthy individuals who had no underlying conditions, experienced acute respiratory failure requiring hospitalization, and were found to frequently expose themselves to vaporized aerosol in July and August 2019.


In 2019, a vaping-related lung illness known as EVALI resulted in 60 deaths and over 2,800 hospitalizations. This illness was caused by the use of illegal THC vape pods containing vitamin E oil. While this oil has FDA approval for use in a variety of products, it is not suitable for inhalation via vaporization. In response to the EVALI outbreak, Oregon and other legal cannabis states have implemented strict regulations prohibiting certain additives such as vitamin E oil, squalene, and propylene glycol in cannabis vape pods.


Health risks associated with inhaling soybean oil have been observed in both food seasoning and production factories. In 2002, a microwave popcorn factory experienced a mysterious outbreak of bronchiolitis obliterans. Officials investigating the incident at the Centers for Disease Control and Prevention found that workers in the factory had lung problems caused by inhaling aerosolized byproducts of heated soybean oil.


Further punishment will depend on the intent of the production.


In the OLCC investigation into YHN's vape pod, flavors such as "Fruit Blend" and "Green Crack" were tested. Independent testing revealed the presence of ingredients that match those found in soybean oil, a substance banned for use in e-cigarettes in Oregon. It was also discovered that YHN's labeling only partially complied with Oregon's regulations for inhalable cannabinoid products.


The ingredient list of the YHN e-cigarette products that were recalled did indeed include artificial flavorings, and the products were correctly classified according to OLCC rules. However, YHN did not follow OLCC requirements to further break down the ingredients in their artificial flavorings to disclose the presence of soybean oil.


YHN may face a fine of $4,950 or have their marijuana license revoked. These are two very different outcomes, and the punishment may depend on whether OLCC determines that the prohibited additives were intentionally added or due to negligent oversight.


Announcement:


This article has been compiled from third-party information and is intended for industry communication and learning purposes only.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS is unable to confirm the authenticity and accuracy of the article's content. The article's translation is only intended for communication and research within the industry.


Due to limitations in the translator's proficiency, the compiled article may not express the same meaning as the original text. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the position and statements of the Chinese government in relation to any issues pertaining to domestic affairs, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
As FDA Reshapes PMTA Reviews and ENDS Enforcement Priorities, CTP Acting Director Bret Koplow to Keynote NATO Event for a Retail Network of 66,000-Plus Stores
Bret Koplow, acting director of the U.S. Food and Drug Administration's Center for Tobacco Products, will deliver a keynote and participate in a fireside chat at the National Association of Tobacco Outlets' Sept. 29-30 conference in Washington. His appearance comes months after the FDA moved to accelerate PMTA reviews and introduced a more differentiated enforcement policy for certain unauthorized ENDS and oral nicotine pouch products. The agency also plans a public list identifying manufacturers and products it does not currently intend to prioritize for enforcement under the May guidance. NATO says its membership includes more than 66,000 retail stores, making product-status transparency and enforcement boundaries directly relevant to the retail sector.
Aug.14
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
Special Report | Altria Subsidiaries Sue FDA to Vacate 2021 PMTA Rule as Agency Moves to Speed Reviews
2Firsts reviewed the original federal court complaint filed by Altria subsidiaries Helix Innovations and NJOY on Sept. 2 challenging FDA’s 2021 PMTA rule. The lawsuit questions whether FDA’s review process complies with the Tobacco Control Act’s 180-day timeline, even as the agency moves to accelerate PMTA reviews and issues more marketing orders. Drawing on the complaint, FDA records, government audits and recent court rulings, 2Firsts examines the legal arguments, supporting evidence and potential implications for the U.S. tobacco review system.
Regulations
Sep.03